People who exceed an annual safety-net threshold for pharmaceutical costs (PBS-listed medicines) are eligible for additional subsidies: the patient copayment per item decreases to the concessional rate of AUS$5.80 (US$5.50) once expenditure exceeds AUS$1,391 [US$1,325]) (as of 2013) in a calendar year. For concessional patiee patients patients, the copayment is not required once expenditure on PBS items exceeds AUS$354 (US$337).